[1] ISAACS A, LINDENMANN J. Virus interference .I. the interferon. Proc R Soc Lond B Biol Sci. 1957;147(927):258-267.
[2] 李晨,李洁.重组人干扰素的研究进展及相关专利申请[J].中国发明与专利,2018,15(2):15-19.
[3] HU JH, CHANG ML, HUANG TJ, et al. Comparison of Compliance and Efficacy of Pegylated Interferon α-2a and α-2b in Adults with Chronic Hepatitis C. J Interferon Cytokine Res. 2019;39(4):205-213.
[4] NINGRUM RA. Human interferon alpha-2b: a therapeutic protein for cancer treatment. Scientifica (Cairo). 2014;970315:1-8.
[5] KALIKI S, BEJJANKI KM, DESAI A, et al. Interferon Alfa 2b for ocular surface squamous neoplasia: factors influencing the treatment response. Semin Ophthalmol. 2019,34(8):465-472.
[6] COENTRO JQ , PUGLIESE E, HANLEY G , et al. Current and upcoming therapies to modulate skin scarring and fibrosis. Adv Drug Deliv Rev. 2019;146:37-59.
[7] BERMAN B, DUNCAN MR. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol. 1989;21(4): 694-702.
[8] LEE JH, KIM SE, LEE AY. Effects of interferon-α2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008;47(2):183-186.
[9] WANG J, JIAO H, STEWART TL, et al. Improvement in postburn hypertrophic scar after treatment with IFN-α2b is associated with decreased fibrocytes. J Interferon Cytokine Res. 2007; 27(11): 921-930
[10] TELASKY C , TREDGET EE, SHEN Q, et al. IFN-α2b Suppresses the Fibrogenic Effects of Insulin-Like Growth Factor-1 in Dermal Fibroblasts. J Interferon Cytokine Res. 1998;18(8):571-577.
[11] TREDGET EE , WANG R, SHEN Q,et al. Transforming Growth Factor-βmRNA and Protein in Hypertrophic Scar Tissues and Fibroblasts: Antagonism by IFN-αand IFN-γ In Vitro and In Vivo. J Interferon Cytokine Res. 2000; 20(2):143-151.
[12] 陆兴安,许明,沈国良,等.干扰素治疗增生性瘢痕机理的研究[J]. 苏州大学学报(医学版),2005,25(6):1091-1103
[13] GHAHARY A, TREDGET EE, SHEN Q. Induction of Collagenase mRNA Expression in Dermal Fibroblasts by IFN-a2b and Determination of the IFN-a2b Responsive Element on 5’-Flanking Regions of Collagenase Promoter. J Interferon Cytokine Res. 2001; 21(8):611-620 .
[14] 黄勇,邢新.干扰素α-2b对瘢痕疙瘩成纤维细胞凋亡及端粒酶活性的影响[J].中华实验外科杂志,2007,24(4):432-434.
[15] 徐少骏,滕建英,谢菁,等.细胞信号传导在激素和干扰素诱导的增殖瘢痕成纤维细胞凋亡中的作用[J].中华整形外科杂志, 2008, 24(1):46-49.
[16] 刘传君,陈东明,徐少骏,等.干扰素治疗增生性瘢痕的机制[J].中华医学美学美容杂志,2002,8(1):33-34.
[17] SCHLUNCK G, MEYER-TER-VEHN T, KLINK T, et al. Conjunctival fibrosis following filtering glaucoma surgery. Exp Eye Res. 2016;142: 76-82.
[18] ANDREW NH, AKKACH S, CASSON RJ. A review of aqueous outflow resistance and its relevance to microinvasive glaucoma surgery .Surv Ophthalmol. 2020;65(1): 18-31.
[19] 沙倩,乔喜珍,聂庆珠,等.不同高分子生物材料抑制小梁切除后瘢痕的形成[J].中国组织工程研究与临床康复,2009,13(8): 1513-1516.
[20] GILLIES M, SU T, SAROSSY M, et al. Interferon-alpha 2b inhibits proliferation of human Tenon’s capsule fibroblasts. Graefes Arch Clin Exp Ophthalmol. 1993;231(2) : 118-121.
[21] WANG XY, CROWSTON GJ, WHITE AJ, et al. Interferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon’sfibroblasts. Clin Exp Ophthalmol.2014; 42(6): 529-538.
[22] 陈君毅,孙兴怀,笪翠弟,等.干扰素α-2b对人眼Tenon囊成纤维细胞纤维化作用的影响[J].中国眼耳鼻喉科杂志,2011,11(5): 277-280.
[23] 张秀兰,梁凌毅,彭大伟,等.青光眼术后滤过区生长因子的表达及干扰素拮抗生长因子作用的初步研究[J].眼科学报, 2001, 17(2):106-110.
[24] 熊新春,杜蜀华,吕源淑,等.干扰素α-2b作为青光眼滤过术后辅助用药的实验研究[J]. 中华眼科杂志,1999,35(1):52-54.
[25] 孙亚杰,林婷婷,何彦津,等.临床常用药物对体外培养的复发性翼状胬肉成纤维细胞的抑制效果比较[J]. 中华实验眼科杂志, 2017,35(6):512-519.
[26] YIN MY, LI H, ZHANG YN, et al. Interferon Alpha-2b eye drops prevent recurrence of pterygium after the bare sclera technique : a single-center, sequential, and controlled study. Cornea. 2019; 38(10): 1239-1244.
[27] Salgado KR, Wendt AR, Fernandes Fagundes NC, et al. Early or delayed palatoplasty in complete unilateral cleft lip and palate patients? A systematic review of the effects on maxillary growth. J Craniomaxillofac Surg.2019;47(11): 1690-1698.
[28] SCHEUERMANN M , VANREUSEL I , CASTEELE EV, et al. Spontaneous bone regeneration after closure of the hard palate cleft: a literature review. J Oral Maxillofac Surg. 2019;77(5): 1074.
[29] 胡广伟,廖天安,王涛,等.明胶海绵与生物蛋白胶在腭裂修复术中松弛切口处理的疗效观察[J].中国美容医学, 2017,26(2): 84-86.
[30] CORNELISSEN AM, VONDEN HOFF IW, MALTHA JC, et al. Effects of interferons on proliferation and collagen synthesis of rat palatal wound fibroblasts. Arch Oral Biol.1999;44(7): 541-547.
[31] 胡超,丁丁,刘安东,等.重组人干扰素α-2b对腭裂术后瘢痕成纤维细胞影响的实验研究[J] 安徽医科大学学报, 2008,43(5):520-523.
[32] 陶明,胡超,丁丁,等.干扰素对腭裂术后裸露骨面瘢痕成纤维细胞生物学影响的实验研究[J]. 中国美容医学,2011,20(6):926-928.
[33] 孟凡伟,刘玉强,史本康,等.干扰素-α2b对尿道瘢痕成纤维细胞生物学的影响[J]. 山东大学学报(医学版),2011,49(12):92-94.
[34] FIRAT F, ULUOCAK N, ERDEMIR F, et al. Evaluation of the effects of omega-3 & interferon alpha-2b administration on partial bladder outlet obstruction in a rat model. Indian J Med Res. 2016;144: 572-579.
[35] GOKCE A, ABDELMAGEED ZY, LASKER GF, et al. Intratunical injection of genetically modified adipose tissue-derived stem cells with human interferon α-2b for treatment of erectile dysfunction in a rat model of tunica albuginealfibrosis. J Sex Med. 2015;12(7): 1533-1544.
[36] 苏云,孟祥俊,于小光,等.干扰素/聚乳酸-羟基乙酸共聚物及壳聚糖/聚乳酸-羟基乙酸共聚物复合膜防止椎板切除术后硬膜外瘢痕粘连的实验[J].中国组织工程研究与临床康复,2008,12(23): 4427-4430.
[37] 孔亚男,陆宏,陈颖,等.青光眼滤过术后瘢痕形成机制及抗瘢痕化研究进展[J].国际眼科杂志,2019,19(10):1688-1691.
[38] 张思敏,亓发芝. 巨噬细胞极化在增生性瘢痕和瘢痕疙瘩中的作用[J].中国免疫学杂志,2019,35(5):639-642.
[39] JIN Q, GUI L, NIU F, et al. Macrophages in keloid are potent at promoting the differentiation and function of regulatory T cells. Exp Cell Res. 2018;362(2):472-476.
[40] VERMA SK, GARIKIPATI VNS, KRISHNAMURTHY P, et al. Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium. Circulation. 2017; 136(10): 940-953.
[41] OGAWA R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3): E606.
[42] GONG YF, ZHANG XM, LIU F, et al. Inhibitory effect of recombinant human endostatin on the proliferation of hypertrophic scar fibroblasts in a rabbit ear model. Eur J Pharmacol. 2016;791:647-654.
|